Membrane technology market to grow at CAGR of 9.3%

2010 witnessed the global membrane technology market reach a value of $5.4 billion, this had increased to $6.4 billion in 2011, and is predicted to surpass $10 billion by 2016, increasing at a compound annual growth rate (CAGR) of 9.3%.

Membrane technology is used in all phases of the pharmaceutical development processes, from laboratory research to large-scale pharmaceutical manufacturing. Applications include lab-scale DNA and protein separation and analysis, sample preparation, drug screening, cell culturing and examination, laboratory and process water purification, virus removal, and bench-, pilot-, and production-scale drug manufacturing.

Substantial changes in the pharmaceutical and biopharmaceutical industries have made membrane separations processes an important part of the production of drugs. Membrane separation processes help ensure safety and efficacy of drugs by eliminating contaminants from the laboratory through large-scale production.

The pharmaceutical market was $2.3 billion in 2010 and $2.7 billion in 2011. It is expected to grow to $4.4 billion in 2016, a CAGR of 9.9% between 2011 and 2016.

The life science laboratory market reached $1.6 billion in 2010 and $1.8 billion in 2011. The market is expected to reach $2.5 billion by 2016, a CAGR of 6.5%.

With regards to membrane separation, the US continues to remain the largest regional market. Growth in the global membrane separation technologies market would be driven by large developing countries worldwide that reel under stressed domestic water resources. Asia-Pacific represents the fastest growing regional market, displaying a CAGR of approximately 8.3% to 2017.

For more information on the membrane technology market, see the latest research: Membrance Technology Market Report

Follow us on Twitter @CandMResearch